Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Bioactivity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts.

Preventive nutrition and food science

Kim SY, Shin KS.
PMID: 24471075
Prev Nutr Food Sci. 2012 Jun;17(2):136-40. doi: 10.3746/pnf.2012.17.2.136.

Trifoliate orange seed extracts (TSEs) were made using either distilled water (TW), ethanol (TE), or n-hexane (TH), to measure total polyphenol contents, DPPH and ABTS radical scavenging activities, and anti-complementary activity. The results showed that the total polyphenol content...

Cite
Kim SY, Shin KS. Bioactivity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts. Prev Nutr Food Sci. 2012;17(2):136-40doi: 10.3746/pnf.2012.17.2.136.
Kim, S. Y., & Shin, K. S. (2012). Bioactivity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts. Preventive nutrition and food science, 17(2), 136-40. https://doi.org/10.3746/pnf.2012.17.2.136
Kim, Seong Yeong, and Shin, Kwang-Soon. "Bioactivity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts." Preventive nutrition and food science vol. 17,2 (2012): 136-40. doi: https://doi.org/10.3746/pnf.2012.17.2.136
Kim SY, Shin KS. Bioactivity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts. Prev Nutr Food Sci. 2012 Jun;17(2):136-40. doi: 10.3746/pnf.2012.17.2.136. PMID: 24471075; PMCID: PMC3866750.
Copy Download .nbib Format: NLM
Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature.

Journal of medical case reports

Yamano T, Morii E, Arai I, Takada T, Aozasa K.
PMID: 20637117
J Med Case Rep. 2010 Jul 17;4:213. doi: 10.1186/1752-1947-4-213.

INTRODUCTION: Small bowel adenocarcinoma is a rare malignancy associated with a poor prognosis and there is little evidence of effective treatment. Recurrent small bowel adenocarcinoma is an intractable disease for which there is little information available regarding its treatment...

Cite
Yamano T, Morii E, Arai I, et al. Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature. J Med Case Rep. 2010;4:213doi: 10.1186/1752-1947-4-213.
Yamano, T., Morii, E., Arai, I., Takada, T., & Aozasa, K. (2010). Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature. Journal of medical case reports, 4213. https://doi.org/10.1186/1752-1947-4-213
Yamano, Tomoki, et al. "Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature." Journal of medical case reports vol. 4 (2010): 213. doi: https://doi.org/10.1186/1752-1947-4-213
Yamano T, Morii E, Arai I, Takada T, Aozasa K. Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature. J Med Case Rep. 2010 Jul 17;4:213. doi: 10.1186/1752-1947-4-213. PMID: 20637117; PMCID: PMC2917439.
Copy Download .nbib Format: NLM
Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class.

Contemporary oncology (Poznan, Poland)

Lemieszek M, Rzeski W.
PMID: 23788896
Contemp Oncol (Pozn). 2012;16(4):285-9. doi: 10.5114/wo.2012.30055. Epub 2012 Sep 29.

Basidiomycete mushrooms represent a valuable source of biologically active compounds with anticancer properties. This feature is primarily attributed to polysaccharides and their derivatives. The anticancer potential of polysaccharides is linked to their origin, composition and chemical structure, solubility and...

Cite
Lemieszek M, Rzeski W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp Oncol (Pozn). 2012;16(4):285-9doi: 10.5114/wo.2012.30055.
Lemieszek, M., & Rzeski, W. (2012). Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemporary oncology (Poznan, Poland), 16(4), 285-9. https://doi.org/10.5114/wo.2012.30055
Lemieszek, Marta, and Rzeski, Wojciech. "Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class." Contemporary oncology (Poznan, Poland) vol. 16,4 (2012): 285-9. doi: https://doi.org/10.5114/wo.2012.30055
Lemieszek M, Rzeski W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp Oncol (Pozn). 2012;16(4):285-9. doi: 10.5114/wo.2012.30055. Epub 2012 Sep 29. PMID: 23788896; PMCID: PMC3687424.
Copy Download .nbib Format: NLM
A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report.

International seminars in surgical oncology : ISSO

Todoroki T, Murata S, Nakagawa Y, Ohkohchi N, Morishita Y.
PMID: 16930493
Int Semin Surg Oncol. 2006 Aug 25;3:22. doi: 10.1186/1477-7800-3-22.

BACKGROUND: Tumor spread beyond the peritoneal cavity in cases of papillary serous adenocarcinoma of the unknown primary (CUP) is a rare late event and carries a poor prognosis.CASE PRESENTATION: A 71-year-old female was referred to our hospital because of...

Cite
Todoroki T, Murata S, Nakagawa Y, et al. A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report. Int Semin Surg Oncol. 2006;3:22doi: 10.1186/1477-7800-3-22.
Todoroki, T., Murata, S., Nakagawa, Y., Ohkohchi, N., & Morishita, Y. (2006). A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report. International seminars in surgical oncology : ISSO, 322. https://doi.org/10.1186/1477-7800-3-22
Todoroki, Takeshi, et al. "A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report." International seminars in surgical oncology : ISSO vol. 3 (2006): 22. doi: https://doi.org/10.1186/1477-7800-3-22
Todoroki T, Murata S, Nakagawa Y, Ohkohchi N, Morishita Y. A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report. Int Semin Surg Oncol. 2006 Aug 25;3:22. doi: 10.1186/1477-7800-3-22. PMID: 16930493; PMCID: PMC1574334.
Copy Download .nbib Format: NLM
Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.

Experimental and therapeutic medicine

Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, Yashiro M, Yamada N, Maeda K, Sawada T, Hirakawa K.
PMID: 22969994
Exp Ther Med. 2012 Jun;3(6):925-930. doi: 10.3892/etm.2012.537. Epub 2012 Apr 02.

Protein-bound polysaccharide K (PSK) is a glycoprotein that is purified from the mushroom Coriolus versicolor. In Japan, PSK is clinically used in combination with anticancer agents following gastric cancer surgery. Evaluation of the response is difficult, as efficacy is...

Cite
Ito G, Tanaka H, Ohira M, et al. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Exp Ther Med. 2012;3(6):925-930doi: 10.3892/etm.2012.537.
Ito, G., Tanaka, H., Ohira, M., Yoshii, M., Muguruma, K., Kubo, N., Yashiro, M., Yamada, N., Maeda, K., Sawada, T., & Hirakawa, K. (2012). Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Experimental and therapeutic medicine, 3(6), 925-930. https://doi.org/10.3892/etm.2012.537
Ito, Gentaro, et al. "Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I." Experimental and therapeutic medicine vol. 3,6 (2012): 925-930. doi: https://doi.org/10.3892/etm.2012.537
Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, Yashiro M, Yamada N, Maeda K, Sawada T, Hirakawa K. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Exp Ther Med. 2012 Jun;3(6):925-930. doi: 10.3892/etm.2012.537. Epub 2012 Apr 02. PMID: 22969994; PMCID: PMC3438816.
Copy Download .nbib Format: NLM
Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo.

Oncology letters

Tsutsumi N, Kohnoe S, Sonoda H, Guntani A, Rikimaru T, Taguchi KI, Tomikawa M, Kakeji Y, Nakashima H, Maehara Y.
PMID: 22866128
Oncol Lett. 2011 Sep 01;2(5):791-796. doi: 10.3892/ol.2011.336. Epub 2011 Jul 04.

Protein-bound polysaccharide-K (PSK) is a biological response modifier that possesses antitumor effects against various tumors. Although an inflammatory response has been considered to play an important role in the development of colorectal cancer, the anti-inflammatory effect of PSK has...

Cite
Tsutsumi N, Kohnoe S, Sonoda H, et al. Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo. Oncol Lett. 2011;2(5):791-796doi: 10.3892/ol.2011.336.
Tsutsumi, N., Kohnoe, S., Sonoda, H., Guntani, A., Rikimaru, T., Taguchi, K. I., Tomikawa, M., Kakeji, Y., Nakashima, H., & Maehara, Y. (2011). Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo. Oncology letters, 2(5), 791-796. https://doi.org/10.3892/ol.2011.336
Tsutsumi, Norifumi, et al. "Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo." Oncology letters vol. 2,5 (2011): 791-796. doi: https://doi.org/10.3892/ol.2011.336
Tsutsumi N, Kohnoe S, Sonoda H, Guntani A, Rikimaru T, Taguchi KI, Tomikawa M, Kakeji Y, Nakashima H, Maehara Y. Protein-bound polysaccharide-K reduces colitic tumors and improves survival of inflammatory bowel disease in vivo. Oncol Lett. 2011 Sep 01;2(5):791-796. doi: 10.3892/ol.2011.336. Epub 2011 Jul 04. PMID: 22866128; PMCID: PMC3408101.
Copy Download .nbib Format: NLM
Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis.

Oncotarget

Ma Y, Wu X, Yu J, Zhu J, Pen X, Meng X.
PMID: 29179503
Oncotarget. 2017 Jul 06;8(51):89108-89118. doi: 10.18632/oncotarget.19059. eCollection 2017 Oct 24.

OBJECTIVE: To assess the comparative efficacy and safety of polysaccharide K (PSK), with or without chemotherapy, for patients with gastrointestinal cancer (GIC) through a systematic review and network meta-analysis.MATERIALS AND METHODS: We performed a network meta-analysis to identify evidence...

Cite
Ma Y, Wu X, Yu J, et al. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis. Oncotarget. 2017;8(51):89108-89118doi: 10.18632/oncotarget.19059.
Ma, Y., Wu, X., Yu, J., Zhu, J., Pen, X., & Meng, X. (2017). Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis. Oncotarget, 8(51), 89108-89118. https://doi.org/10.18632/oncotarget.19059
Ma, Yan, et al. "Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis." Oncotarget vol. 8,51 (2017): 89108-89118. doi: https://doi.org/10.18632/oncotarget.19059
Ma Y, Wu X, Yu J, Zhu J, Pen X, Meng X. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis. Oncotarget. 2017 Jul 06;8(51):89108-89118. doi: 10.18632/oncotarget.19059. eCollection 2017 Oct 24. PMID: 29179503; PMCID: PMC5687673.
Copy Download .nbib Format: NLM
Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review.

Chinese medicine

Lam CS, Cheng LP, Zhou LM, Cheung YT, Zuo Z.
PMID: 32724333
Chin Med. 2020 Jul 25;15:75. doi: 10.1186/s13020-020-00356-4. eCollection 2020.

BACKGROUND: Lingzhi and Yunzhi are medicinal mushrooms commonly used with cytotoxic chemotherapy in cancer patients in Asian countries. The current systematic review aims to identify potential pharmacokinetic or pharmacodynamic interactions from the existing literature to ensure their effective and...

Cite
Lam CS, Cheng LP, Zhou LM, et al. Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review. Chin Med. 2020;15:75doi: 10.1186/s13020-020-00356-4.
Lam, C. S., Cheng, L. P., Zhou, L. M., Cheung, Y. T., & Zuo, Z. (2020). Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review. Chinese medicine, 1575. https://doi.org/10.1186/s13020-020-00356-4
Lam, Chun Sing, et al. "Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review." Chinese medicine vol. 15 (2020): 75. doi: https://doi.org/10.1186/s13020-020-00356-4
Lam CS, Cheng LP, Zhou LM, Cheung YT, Zuo Z. Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review. Chin Med. 2020 Jul 25;15:75. doi: 10.1186/s13020-020-00356-4. eCollection 2020. PMID: 32724333; PMCID: PMC7382813.
Copy Download .nbib Format: NLM
Polysaccharide K suppresses angiogenesis in colon cancer cells.

Experimental and therapeutic medicine

Satoh Y, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.
PMID: 23181101
Exp Ther Med. 2012 Sep;4(3):370-374. doi: 10.3892/etm.2012.632. Epub 2012 Jul 04.

The protein-bound polysaccharide K (PSK) is used as a non-specific immunotherapeutic agent for the treatment of colon cancer. Little research, however, has been conducted on its association with angiogenesis, which is a prognostic factor markedly correlated with hematogenous metastases....

Cite
Satoh Y, Goi T, Nakazawa T, et al. Polysaccharide K suppresses angiogenesis in colon cancer cells. Exp Ther Med. 2012;4(3):370-374doi: 10.3892/etm.2012.632.
Satoh, Y., Goi, T., Nakazawa, T., Kimura, Y., Hirono, Y., Katayama, K., & Yamaguchi, A. (2012). Polysaccharide K suppresses angiogenesis in colon cancer cells. Experimental and therapeutic medicine, 4(3), 370-374. https://doi.org/10.3892/etm.2012.632
Satoh, Yoshiki, et al. "Polysaccharide K suppresses angiogenesis in colon cancer cells." Experimental and therapeutic medicine vol. 4,3 (2012): 370-374. doi: https://doi.org/10.3892/etm.2012.632
Satoh Y, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A. Polysaccharide K suppresses angiogenesis in colon cancer cells. Exp Ther Med. 2012 Sep;4(3):370-374. doi: 10.3892/etm.2012.632. Epub 2012 Jul 04. PMID: 23181101; PMCID: PMC3503532.
Copy Download .nbib Format: NLM
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive .

Frontiers in microbiology

Choi M, Hegerle N, Nkeze J, Sen S, Jamindar S, Nasrin S, Sen S, Permala-Booth J, Sinclair J, Tapia MD, Johnson JK, Mamadou S, Thaden JT, Fowler VG, Aguilar A, Terán E, Decre D, Morel F, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Lin YT, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM.
PMID: 32595624
Front Microbiol. 2020 Jun 12;11:1249. doi: 10.3389/fmicb.2020.01249. eCollection 2020.

No abstract available.

Cite
Choi M, Hegerle N, Nkeze J, et al. The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive . Front Microbiol. 2020;11:1249doi: 10.3389/fmicb.2020.01249.
Choi, M., Hegerle, N., Nkeze, J., Sen, S., Jamindar, S., Nasrin, S., Sen, S., Permala-Booth, J., Sinclair, J., Tapia, M. D., Johnson, J. K., Mamadou, S., Thaden, J. T., Fowler, V. G., Aguilar, A., Terán, E., Decre, D., Morel, F., Krogfelt, K. A., Brauner, A., Protonotariou, E., Christaki, E., Shindo, Y., Lin, Y. T., Kwa, A. L., Shakoor, S., Singh-Moodley, A., Perovic, O., Jacobs, J., Lunguya, O., Simon, R., Cross, A. S., & Tennant, S. M. (2020). The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive . Frontiers in microbiology, 111249. https://doi.org/10.3389/fmicb.2020.01249
Choi, Myeongjin, et al. "The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive ." Frontiers in microbiology vol. 11 (2020): 1249. doi: https://doi.org/10.3389/fmicb.2020.01249
Choi M, Hegerle N, Nkeze J, Sen S, Jamindar S, Nasrin S, Sen S, Permala-Booth J, Sinclair J, Tapia MD, Johnson JK, Mamadou S, Thaden JT, Fowler VG, Aguilar A, Terán E, Decre D, Morel F, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Lin YT, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM. The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive . Front Microbiol. 2020 Jun 12;11:1249. doi: 10.3389/fmicb.2020.01249. eCollection 2020. PMID: 32595624; PMCID: PMC7303279.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries